India records 2,58,089 new Covid infections including 8,209 Omicron cases, 385 deaths

India saw a single-day rise of 2,58,089 new coronavirus infections taking the tally of cases to 3,73,80,253, which included 8,209 cases of the Omicron variant detected so far, according to data updated by the Union Health Ministry on Monday.

A total of 8,209 cases of the Omicron variant have been detected across 29 states and union territories, out of which 3,109 have recovered or migrated. Maharashtra recorded the maximum 1,738 cases of the Omicron variant, followed by West Bengal 1,672, Rajasthan 1,276, Delhi 549, Karnataka 548 and Kerala 536 cases.

According to experts, it is not possible to undertake genome sequencing of each and every sample but this current wave is largely being driven by Omicron.

The number of active COVID-19 cases have increased to 16,56,341, the highest in around 230 days, while the death toll has climbed to 4,86,451 with 385 daily fatalities, the data updated at 8 am stated.

The active cases account for 4.43 per cent of the total infections, while the national COVID-19 recovery rate has decreased to 94.27 per cent, the ministry said.

An increase of 1,05,964 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.

The daily positivity rate was recorded at 19.65 per cent, while the weekly positivity rate was 14.41 per cent, according to the ministry.

The number of people who have recuperated from the disease surged to 3,52,37,461, while the case fatality rate was recorded at 1.30 per cent.

The cumulative doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 157.20 crore.

India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 2020; 30 lakh on August 23; 40 lakh on September 5; and 50 lakh on September 16. It went past 60 lakh on September 28; 70 lakh on October 11; 80 lakh on October 29; 90 lakh on November 20; and surpassed the one-crore mark on December 19. India crossed the grim milestone of two crore infections on May 4 and three crore cases on June 23.

  • Related Posts

    • Pharma
    • December 24, 2024
    • 15 views
    FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes

    The FDA today approved the first generic referencing the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide (Victoza), an 18 mg/3 mL injection, to improve glycemic control in patients aged 10 years and older…

    • Pharma
    • December 24, 2024
    • 74 views
    Aurobindo Pharma shares jump 2% after UK arm secures regulatory approval for cancer drug

    Aurobindo Pharma shares jumped 2% to an intraday high of Rs 1,265 on the BSE after its wholly owned step-down subsidiary CuraTeQ Biologics received approval from the UK‘s Medicines and Healthcare products Regulatory Agency…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes

    FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes

    HC denies bail to pharma company owner for manufacturing spurious drugs

    HC denies bail to pharma company owner for manufacturing spurious drugs

    Aurobindo Pharma shares jump 2% after UK arm secures regulatory approval for cancer drug

    Aurobindo Pharma shares jump 2% after UK arm secures regulatory approval for cancer drug

    Ho-Lis-Tic, are ‘bols’ of Cure Tabla Maestro Zakir Hussain missed

    Ho-Lis-Tic, are ‘bols’ of Cure Tabla Maestro Zakir Hussain missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations